NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
Back to search
Official data from USPTO
NOCTURNAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOCTURNAL
ST13
US500000097175653Class
35, 36, 42
Filing
97175653
Registration
7141791
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
08/22/2023
Trademark type
Word
Nice classes
35, 36, 42
Filing date
12/16/2021
Registration date
08/22/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/22/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2012-04-00
First use in commerce
2012-04-00
Drawing code
4
Owner type
16
Owner location
Durham, NC
Examiner
SIRIGNANO, EMMA
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nocturnal Product Development, LLC
Representatives
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
business consulting servicesproviding assistance in the development of innovation-driven business strategies and creative ideation; business consulting in the field of clinical trialsassisting with clinical data and regulatory submission management on behalf of medicalbiopharmaceuticalbiotechnology companies; business consulting servicesproviding information to companies and universities on managing grant funding from federalstatelocal governments for clinical research and clinical trials; business consulting servicesmaintaining design history filesperforming business risk analysisplanning and executing verification and validation activities that support clinical investigations in domestic and international settingsproviding independent review of clinical trials for business purposesdeveloping regulatory strategies for obtaining domestic and international approvals in the nature of clinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with applications for drug and medical device approvalassisting businesses in preparing and filing applications for and managing government grant funding in the field of medical devices and products; business consulting servicesassisting with clinical trial submissionsregulatory submission managementassisting others in preparing and filing applications for new drugs and new medical devices with governmental regulatory bodies; business consulting servicesassisting in obtaining domestic and international approvals by developing regulatory strategies and authoring product approval and product registration submissions; business consulting servicesproject management services to identify and mitigate potential risks in complex projects; business consulting servicesconsultation in the fields of medical products and medical devices
Class 36
business financial and funding consulting servicesproviding information that advises companies and universities seeking to obtain grant funding from federalstatelocal governments for clinical research and clinical trials
Class 42
product research and development in the fields of medical products and medical devices; mechanical engineering services for electronics packagingstructural finite element analysisthermal analysis; product design and development in the field of medical devicesdeveloping extensive analog circuitrydigital circuitryembedded firmwareapplication software to meet the demands of medical products and medical devices; product design and development in the field of medical deviceselectromagnetic compatibility (EMC) and electrical safety testing to meet the demands of international regulatory standards; product design and development in the field of medical products and medical devicesdevelopment of laser systemsfiber and electro-opticsbiophotonics for spectroscopy and optical characterization of living tissue via both diffuse reflectance and fluorescence; cloud-based Platform as a Service (PaaS) featuring computer software platforms that communicate with and collect data from medical products and medical devices; product design and development in the field of medical products and medical devicesdeveloping extensive analog circuitrydigital circuitryembedded firmwareapplication software for use with medical products and medical devices including topical electronic medical devicesactive electronic implantsimplantable pacemakersdefibrillatorsdiagnostic cathetersablation cathetersneurostimulators; business product development consulting servicesproviding assistance in the development of leading-edge technologies for medicalbiopharmaceuticalbiotechnology companies
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/07/2023
GNRT
NON-FINAL ACTION E-MAILED
04/07/2023
CNRT
NON-FINAL ACTION WRITTEN
04/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/22/2022
GNRT
NON-FINAL ACTION E-MAILED
12/22/2022
CNRT
NON-FINAL ACTION WRITTEN
12/22/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2022
GNRT
NON-FINAL ACTION E-MAILED
09/26/2022
CNRT
NON-FINAL ACTION WRITTEN
09/26/2022
DOCK
ASSIGNED TO EXAMINER
09/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/21/2021
NWAP
NEW APPLICATION ENTERED
12/20/2021
Continuous trademark protection
Get notified about every new filing that threatens NOCTURNAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.